AbbVie ABBV Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbbVie's deferred tax assets and other non-current assets?
- AbbVie (ABBV) reported deferred tax assets and other non-current assets of $10.54B in Q1 2026.
- How has AbbVie's deferred tax assets and other non-current assets changed year-over-year?
- AbbVie's deferred tax assets and other non-current assets increased by 14.6% year-over-year, from $9.19B to $10.54B.
- What is the long-term trend for AbbVie's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), AbbVie's deferred tax assets and other non-current assets has grown at a 17.2% compound annual growth rate (CAGR), from $4.85B to $10.72B.